WhaleCreep

Woodline Partners LP 13F holdings, Q1 2020

Hedge fundSEC filingsCompare with another fundHoldings as of 2020-03-31, filed 2020-05-15

Woodline Partners LP disclosed 136 US equity positions worth $1.4bn in its Q1 2020 13F filing. Its largest position is PFE at 4.7% of the reported book, followed by SPY and GOOGL. Versus Q4 2019 it opened 76 new positions, added to 18, reduced 42 and exited 45.

$1.4bn
Reported equity book
Sum of the long US equity positions in the filing, at the values filed. Options are excluded.
136
Positions
Distinct securities in the equity book with a reported value above zero. Options are excluded.
4.7%
Largest position
The largest single position as a share of the reported equity book.
29.7%
Top 10 weight
The ten largest positions together, as a share of the reported equity book.
64
Effective positions
1 / HHI of portfolio weights: the number of equal-weight positions the book behaves like.
27
Quarters on file since Q4 2019
Quarters for which this manager's 13F holdings are on record.

Holdings

Against Q4 2019: 76 new, 18 added, 42 reduced, 45 exited

50 of 136
PFE PFIZER INCHealthcare4.7%$65.7m2.01m–new
SPY SPDR S&P 500 ETF Trust–3.3%$46.8m181,440–new
GOOGL ALPHABET INCCommunication Services3.3%$46.5m40,031–new
AMAT APPLIED MATLS INCTechnology3.2%$45.4m990,233–new
SGENEUR SEATTLE GENETICS INC–3.0%$42.0m364,333−49%reduced
HORIZON THERAPEUTICS PUB L no ticker–2.7%$37.7m1.27m−40%reduced
FIS FIDELITY NATL INFORMATION SVTechnology2.6%$36.2m297,331−18%reduced
APH AMPHENOL CORPTechnology2.4%$33.8m463,606−7.0%reduced
BDX BECTON DICKINSON & COHealthcare2.3%$31.6m137,328−30%reduced
BIDU BAIDU INCCommunication Services2.1%$29.8m295,630−1.6%reduced
LLY ELI LILLY & COHealthcare2.1%$29.2m210,393−4.9%reduced
ADI ANALOG DEVICES INCTechnology2.0%$27.8m309,764–new
IMMU IMMUNOMEDICS INC–1.9%$26.2m1.94m+238%added
GPN GLOBAL PMTS INCIndustrials1.5%$21.4m148,388−7.8%reduced
STX SEAGATE TECHNOLOGY PLCTechnology1.5%$20.7m423,291−54%reduced
MARVELL TECHNOLOGY GROUP LTD no ticker–1.5%$20.5m906,665−54%reduced
BAX BAXTER INTL INCHealthcare1.5%$20.5m252,032+203%added
FISV FISERV INC–1.5%$20.4m214,400–new
ALXN ALEXION PHARMACEUTICALS INC–1.4%$19.8m220,149+93%added
GWPH GW PHARMACEUTICALS PLC–1.4%$19.1m218,525+86%added
ATVIEUR ACTIVISION BLIZZARD INC–1.3%$18.9m317,615−72%reduced
MU MICRON TECHNOLOGY INCTechnology1.3%$18.8m446,566−54%reduced
ZNGAEUR ZYNGA INC–1.3%$18.4m2.68m–new
TTWO TAKE-TWO INTERACTIVE SOFTWARCommunication Services1.3%$17.7m149,234–new
ZYME ZYMEWORKS INCHealthcare1.1%$15.8m444,334+63%added
INTC INTEL CORPTechnology1.1%$15.7m290,745–new
CHTR CHARTER COMMUNICATIONS INCCommunication Services1.0%$14.7m33,664–new
KDMN KADMON HLDGS INC–1.0%$14.5m3.47m+173%added
PRNB PRINCIPIA BIOPHARMA INC–1.0%$14.4m242,776–new
AAPL APPLE INCTechnology1.0%$13.7m54,027–new
ZGNXEUR ZOGENIX INC–1.0%$13.6m551,155+200%added
MCK MCKESSON CORPHealthcare1.0%$13.4m99,295–new
REGN REGENERON PHARMACEUTICALSHealthcare1.0%$13.4m27,477–new
COR CENCORA INCHealthcare0.9%$12.9m146,007–new
TMUS T-MOBILE US INCCommunication Services0.9%$12.2m145,550–new
ICUI ICU MED INCHealthcare0.8%$11.7m57,903−7.5%reduced
DRNAUSD DICERNA PHARMACEUTICALS INC–0.8%$11.6m632,100+70%added
BMRN BIOMARIN PHARMACEUTICAL INCHealthcare0.8%$11.3m134,149−15%reduced
UNH UNITEDHEALTH GROUP INCHealthcare0.8%$11.2m44,843–new
EW EDWARDS LIFESCIENCES CORPHealthcare0.8%$10.8m57,461–new
VSH VISHAY INTERTECHNOLOGY INCTechnology0.8%$10.7m741,610–new
LYFT LYFT INCTechnology0.8%$10.7m396,892–new
PTCT PTC THERAPEUTICS INCHealthcare0.7%$10.5m235,286−26%reduced
MYLAN NV no ticker–0.7%$10.4m697,226–new
STM STMICROELECTRONICS N VTechnology0.7%$10.1m472,310−34%reduced
SNX TD SYNNEX CORPORATIONTechnology0.7%$9.7m132,844−32%reduced
TFX TELEFLEX INCORPORATEDHealthcare0.7%$9.6m32,780+16%added
MOH MOLINA HEALTHCARE INCHealthcare0.7%$9.5m68,276–new
ABT ABBOTT LABORATORIESHealthcare0.7%$9.5m120,616–new
SMTC SEMTECH CORPTechnology0.7%$9.3m248,861+152%added

Exited since Q4 2019

45 rows
TXN TEXAS INSTRS INC2.8%$69.5m
META META PLATFORMS INC2.6%$63.0m
ASML ASML HLDG NV2.5%$60.0m
GILD GILEAD SCIENCES INC2.3%$55.1m
CMCSA COMCAST CORP NEW2.2%$53.3m
EA ELECTRONIC ARTS INC1.9%$46.7m
TSM TAIWAN SEMICONDUCTOR MANUFAC1.8%$43.6m
BSX BOSTON SCIENTIFIC CORP1.5%$37.6m
BMY BRISTOL-MYERS SQUIBB CO1.5%$35.5m
CNC CENTENE CORP DEL1.4%$34.9m
AMGN AMGEN INC1.2%$29.9m
TER TERADYNE INC1.2%$29.5m
MA MASTERCARD INC1.2%$28.9m
ZBH ZIMMER BIOMET HOLDINGS INC1.2%$28.3m
KLAC KLA CORP1.1%$26.9m
SYK STRYKER CORPORATION1.0%$25.7m
KEYS KEYSIGHT TECHNOLOGIES INC1.0%$25.3m
OPTU OPTIMUM COMMUNICATIONS INC1.0%$23.4m
CTLTEUR CATALENT INC0.9%$23.1m
XRAY DENTSPLY SIRONA INC0.9%$22.6m
LITE LUMENTUM HLDGS INC0.9%$22.0m
CI THE CIGNA GROUP0.9%$21.7m
HUM HUMANA INC0.9%$20.9m
INCY INCYTE CORP0.8%$18.9m
0VVB PARAMOUNT GLOBAL0.7%$16.8m
QCOM QUALCOMM INC0.7%$16.8m
BKNG BOOKING HOLDINGS INC0.7%$16.7m
NVST ENVISTA HOLDINGS CORPORATION0.6%$14.9m
LSCC LATTICE SEMICONDUCTOR CORP0.6%$13.5m
DIS DISNEY WALT CO0.5%$13.3m
TURNING POINT THERAPEUTICS I no ticker0.5%$12.4m
CVS CVS HEALTH CORP0.5%$11.8m
AVTR AVANTOR INC0.5%$11.2m
NVROEUR NEVRO CORP0.3%$8.1m
CSCO CISCO SYS INC0.3%$7.7m
ASND ASCENDIS PHARMA A/S0.3%$7.7m
NBIX NEUROCRINE BIOSCIENCES INC0.3%$7.7m
TDC TERADATA CORP DEL0.2%$5.3m
PYPL PAYPAL HLDGS INC0.2%$5.3m
UNIQURE NV no ticker0.2%$5.3m
RTRXEUR RETROPHIN INC0.2%$4.0m
AVROBIO INC no ticker0.2%$3.9m
WWEUSD WORLD WRESTLING ENTMT INC0.07%$1.7m
DCPHEUR DECIPHERA PHARMACEUTICALS IN0.06%$1.4m
KPTI KARYOPHARM THERAPEUTICS INC0.03%$732k

Sector mix

  • Unclassified32.5%
  • Healthcare28.5%
  • Technology24.1%
  • Communication Services11.2%
  • Consumer Cyclical2.1%
  • Industrials1.5%

Book over time

Every quarter on file (27)
QuarterPositionsEquity book
Q2 20261,011$32.4bn
Q1 20261,022$26.4bn
Q4 20251,009$25.8bn
Q3 2025870$21.2bn
Q2 2025911$18.9bn
Q1 2025891$15.4bn
Q4 2024916$14.8bn
Q3 2024584$11.8bn
Q2 2024542$10.4bn
Q1 2024525$10.8bn
Q4 2023464$9.2bn
Q3 2023580$8.5bn
Q2 2023615$8.4bn
Q1 2023618$7.1bn
Q4 2022742$7.3bn
Q3 2022738$6.8bn
Q2 2022791$6.1bn
Q1 2022708$6.0bn
Q4 2021693$6.8bn
Q3 2021671$6.0bn
Q2 2021586$5.4bn
Q1 2021427$4.5bn
Q4 2020216$3.8bn
Q3 2020178$3.1bn
Q2 2020147$2.5bn
Q1 2020136$1.4bn
Q4 2019105$2.4bn

Where Woodline Partners LP was early

11 rows
RCUS ARCUS BIOSCIENCES INCQ1 20205 of 990.10%1.0%20Held at last filing, Q2 2026+122%
RVMD REVOLUTION MEDICINES INCQ1 20205 of 1640.09%1.3%25Held at last filing, Q2 2026+755%
VSH VISHAY INTERTECHNOLOGY INCQ1 20206 of 1340.8%1.9%25Exited by Q2 2026+25%
ADI ANALOG DEVICES INCQ1 202013 of 2022.0%2.1%15Held at last filing, Q2 2026+343%
LYFT LYFT INCQ1 202022 of 2580.8%1.0%11Exited by Q4 2025−18%
ALKS ALKERMES PLCQ2 20206 of 1341.4%1.4%21Held at last filing, Q2 2026+170%
LEGN LEGEND BIOTECH CORPQ2 20206 of 1210.3%1.2%23Held at last filing, Q2 2026−32%
ALLO ALLOGENE THERAPEUTICS INCQ2 20208 of 940.2%1.1%25Held at last filing, Q2 2026−95%
1K0 IGM BIOSCIENCES INCQ3 20205 of 680.2%1.3%20Exited by Q3 2025–
VOR VOR BIOPHARMA INCQ1 20214 of 661.1%1.1%15Held at last filing, Q2 2026−98%
PR PERMIAN RESOURCES CORPQ2 202312 of 1430.8%1.5%11Exited by Q1 2026+28%

Concentration and tenure

2.8%
Median largest position, all quarters
The largest single position as a share of the reported equity book.
15.8%
Median top 10 weight, all quarters
The ten largest positions together, as a share of the reported equity book.
Diversified
Style, by median largest position
2
Median completed holding, quarters